Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US. The FDA sent the Danish ...

Novo Nordisk said that if approved for use, insulin icodec would reduce the number of basal insulin injections needed per year for type 2 diabetics from 365 to 52, a significant reduction in ...

Announcing a new article publication for BIO Integration journal.   Diabetes, a common metabolic condition, poses a substantial health burden worldwide. To revolutionize diabetes management, enhance ...

On days 2–5, pancreatic endocrine clamps were performed using somatostatin infusions of somatostatin and/or selective replacement of insulin and glucagon; day 2, GLP-1 plus basal insulin and ...

The patient was advised strict glycaemic control. A comprehensive management plan was prepared with the opinion of an endocrinologist. The patient was prescribed basal-bolus insulin therapy that ...

Focus on Market Expansion and Operational Excellence: Insulet is expanding its global presence in a targeted and strategic manner. The company is now shifting from Omnipod GO to Omnipod 5 as its ...

Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...

On Wednesday, the Senate will hold the first of two scheduled hearings to consider the nomination of Robert F. Kennedy Jr. to lead the nation’s health care apparatus as HHS secretary.

That included several executive orders targeting healthcare costs. Multiple viral posts on social media claim that Trump has cancelled the monthly $35 cap on insulin, which became standard for all ...

Minnesota Attorney General Keith Ellison on Monday announced a settlement in a lawsuit against insulin manufacturer Novo Nordisk. Minnesota residents will now be able to get Novo Nordisk insulin ...